drugset / Trial / NCT00413790
Pharmacologic Effects of Darifenacin and Tolterodine on Cardiovascular Parameters in Healthy Subjects
RandomizedCrossoverDouble-blindTreatment
Summary
This study will evaluate the pharmacologic effects of exposure to darifenacin and tolterodine on cardiovascular parameters in healthy subjects 50 years of age and older
Timeline
- Start
- 2006-11
- Primary completion
- —
- Completion
- 2007-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Darifenacin | Small molecule | 15 mg | — |
| Comparator | Tolterodine | Small molecule | 4 mg | — |
Indications
No indication recorded.